Tivicay approved in Europe in new dispersible tablet for children with HIVViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living Share XTivicay approved in Europe in new dispersible tablet for children with HIVhttps://pharmaphorum.com/news/tivicay-approved-in-europe-in-new-dispersible-tablet-for-children-with-hiv/
Amgen’s Enbrel heads ICER list of unjustified US price risesUS cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and Share XAmgen’s Enbrel heads ICER list of unjustified US price riseshttps://pharmaphorum.com/news/icer-lists-top-unjustified-drug-price-rises-headed-by-amgens-enbrel/
Fishawack Health acquires The Hive Health GroupUK comms agency Fishawack Health has acquired The Hive Health Group and its two brands Hive Health and Share XFishawack Health acquires The Hive Health Grouphttps://pharmaphorum.com/news/fishawack-health-acquires-the/
AmerisourceBergen buys Walgreens Boots Alliance wholesaling business for $6.5bnUS wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 Share XAmerisourceBergen buys Walgreens Boots Alliance wholesaling business for $6.5bnhttps://pharmaphorum.com/news/amerisourcebergen-buys-walgreens-boots-alliance-wholesaling-business-for/
Health strategy consultancy CREATION.co makes two senior hiresHealth strategy consultancy CREATION.co has made two senior appointments, with former government analyst Tom Bourne and former TV Share XHealth strategy consultancy CREATION.co makes two senior hireshttps://pharmaphorum.com/news/health-strategy-consultancy-creation-co-makes-two-senior-hires/
Pfizer drops the blue pill, kicks off 2021 with new DNA logoPharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – Share XPfizer drops the blue pill, kicks off 2021 with new DNA logohttps://pharmaphorum.com/news/pfizer-drops-the-blue-pill-kicks-off-2021-with-new-dna-logo/
Ex-Resolute co-founder Blackburn starts hybrid agency Certain HealthFormer joint founder and owner of Resolute Communications and Real Science Paul Blackburn has launched a new hybrid Share XEx-Resolute co-founder Blackburn starts hybrid agency Certain Healthhttps://pharmaphorum.com/news/ex-resolute-co-founder-blackburn-starts-hybrid-agency-certain-health/
AZ closes $400 million Atacand sale to Germany’s CheplapharmAstraZeneca has completed the sell-off of another mature product, hiving off its Atacand cardiovascular franchise to Cheplapharm as Share XAZ closes $400 million Atacand sale to Germany’s Cheplapharmhttps://pharmaphorum.com/news/az-closes-400-million-atacand-sale-to-germanys-cheplapharm/
UK parliament backs EU trade deal, as industry sifts through detailThe post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some Share XUK parliament backs EU trade deal, as industry sifts through detailhttps://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/
